Dr. Manon Spaander about Colorectal Cancer Screening Programs in the Netherlands.

24. November 2017
Name: Dr. Manon Spaander
Position: Professor in Gastroenterology
Thema: Colorectal Cancer Screening Programs in the Netherlands

“One of the biggest problems is how to share national data [across borders] without hindering the privacy of the population”

Dr. Manon Spaander, professor in Gastroenterology at the Department of Gastroenterology of the Erasmus University Medical Center in Rotterdam, talks about her insights as a regional coordinator for the Dutch screening organization in the South- West of the Netherlands.

As Colorectal cancer (CRC) is a major cause of mortality and morbidity worldwide, Mrs. Spaanders empathizes the importance of securing a high participation rate of the population in screening programs. Therefore, new technologies such as Big data are used on both the data of the programs’ pilot studies and a nationwide database. The data analysis have shown, “that there is an effect of social status and gender on the participation rate”: People who are said to be in the “middle class” have upheld the highest rate of participation.

Furthermore, Mrs. Spaander states that the communication about certain illnesses such as cancer are handled very differently across different European countries. In order to resolve this conflict and to enable a clear communication and information of a patient within the screening program, alternative communication strategies had to be used.

Finally, one of the biggest problems in the pan-European collaboration and the transfer of insights gained within a specific country is how to enable secure information sharing without affecting a populations privacy.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInEmail this to someone
DigitalisierungE-HealthHIMSS Impact